FDA product code MWA: System, Nucleic Acid Amplification, Mycobacterium Tuberculosis Complex

MWA is the FDA product code for system, nucleic acid amplification, mycobacterium tuberculosis complex. It is a Class II device, regulated under 21 CFR 866.3372 and reviewed by the Microbiology panel. Devices under MWA reach the market by 510(k); FDA lists no cleared 510(k)s for it. 2 PMA applications cite this product code. FDA has posted 2 recalls for MWA devices.

Definition

intended to detect Mycobacterium tuberculosis complex nucleic acids extracted from human respiratory specimens. These devices are non-multiplexed and intended to be used as an aid in the diagnosis of pulmonary tuberculosis when used in conjunction with clinical and other laboratory findings.

Classification

FieldValue
Device nameSystem, Nucleic Acid Amplification, Mycobacterium Tuberculosis Complex
Device classClass II
Regulation21 CFR 866.3372
Review panelMI — Microbiology
Medical specialtyMicrobiology
Premarket route510(k)

Recalls for MWA devices

2 product recalls in 2 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2012-11-28.

Frequently asked questions

What is FDA product code MWA?

MWA is the FDA product code for system, nucleic acid amplification, mycobacterium tuberculosis complex. It is a Class II device, regulated under 21 CFR 866.3372 and reviewed by the Microbiology panel.

What device class is MWA?

Class II, regulation 21 CFR 866.3372. Typical premarket route: 510(k).

Have MWA devices been recalled?

Yes: 2 product recalls across 2 recall events; the most recent began 2012-11-28.

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times